Federal Register / Vol. 66, No. 103 / Tuesday, May 29, 2001 / Notices 29157

Name of Committee: National Heart, Lung,

and Blood Institute Special Emphasis Panel

RFA: HL–01–004 (Blood and Marrow

Transplant Clinical Research Network).

Date: June 28–29, 2001.

Time: 7 PM to 5 PM.

Agenda: To review and evaluate grant

applications.

Place: Mariott Wardman Park Hotel, 2660

Woodley Road NW., Washington, DC 20008.

Contact Person: Diane M. Reid, MD,

Review Branch, Room 7182, Division of

Extramural Affairs, National Heart, Lung, and

Blood Institute, National Institutes of Health,

Bethesda, MD 20892, (301) 435–0277.

(Catalogue of Federal Domestic Assistance

Program Nos. 93.233, National Center for

Sleep Disorders Research; 93.837, Heart and

Vascular Diseases Research; 93.838, Lung

Diseases Research; 93.839, Blood Diseases

and Resources Research, National Institutes

of Health, HHS)

Dated: May 22, 2001.

LaVerne Y. Stringfield,

Director, Office of Federal Advisory

Committee Policy.

[FR Doc. 01–13338 Filed 5–25–01; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Institute on Drug Abuse;

Notice of Closed Meetings

Pursuant to section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

meetings.

The meetings will be closed to the

public in accordance with the

provisions set forth in sections

552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,

as amended. The grant applications and

the discussions could disclose

confidential trade secrets or commercial

property such as patentable material,

and personal information concerning

individuals associated with the grant

applications, the disclosure of which

would constitute a clearly unwarranted

invasion of personal privacy.

Name of Committee: National Institute on

Drug Abuse Initial Review Group, Treatment

Research Subcommittee.

Date: June 7–8, 2001.

Time: 9 AM to 3 PM.

Agenda: To review and evaluate grant

applications.

Place: Radisson Barcelo Hotel, 2121 P

Street NW, Washington, DC 20037.

Contact Person: Kesinee Nimit, MD, Health

Scientist Administrator, Office of Extramural

Affairs, National Institute on Drug Abuse,

National Institutes of Health, DHHS, 6001

Executive Boulevard, Room 3158, MSC 9547,

Bethesda, MD 20892–9547, (301) 435–1432.

This notice is being published less than 15

days prior to the meeting due to the timing

limitations imposed by the review and

funding cycle.

Name of Committee: National Institute on

Drug Abuse Initial Review Group, Health

Services Research Subcommittee.

Date: June 7–8, 2001.

Time: 9 AM to 5 PM.

Agenda: To review and evaluate grant

applications.

Place: Radisson Barcelo Hotel, 2121 P

Street NW, Washington, DC 20037.

Contact Person: Marina L. Volkov, Ph.D,

Health Scientist Administrator, Office of

Extramural Affairs, National Institute on

Drug Abuse, National Institutes of Health,

DHHS, 6001 Executive Boulevard, Room

3158, MSC 9547, Bethesda, MD 20892–9547,

(301) 435–1433.

This notice is being published less than 15

days prior to the meeting due to the timing

limitations imposed by the review and

funding cycle.

Name of Committee: National Institute on

Drug Abuse Special Emphasis Panel,

Treatment Research.

Date: June 7, 2001.

Time: 1 PM to 4 PM.

Agenda: To review and evaluate grant

applications.

Place: Radisson Barcelo Hotel, 2121 P

Street NW, Washington, DC 20037.

Contact Person: Mark R. Green, Ph.D,

Chief, CEASRB, Office of Extramural Affairs,

National Institute on Drug Abuse, National

Institutes of Health, DHHS, Suite 3158, 6001

Executive Boulevard, Bethesda, MD 20892–

9547, (301) 435–1431.

This notice is being published less than 15

days prior to the meeting due to the timing

limitations imposed by the review and

funding cycle.

Name of Committee: National Institute on

Drug Abuse Special Emphasis Panel,

International Studies on Drug Abuse and

HIV/AIDS.

Date: June 27, 2001.

Time: 8 AM to 6 PM.

Agenda: To review and evaluate grant

applications.

Place: Courtyard by Marriott, 1600 Rhode

Island Ave., NW., Washington, DC 20037.

Contact Person: William C. Grace, Ph.D,

Deputy Director, Office of Extramural Affairs,

National Institute on Drug Abuse, National

Institutes of Health, DHHS, 6001 Executive

Boulevard, Room 3158, MSC 9547, Bethesda,

MD 20892–9547, (301) 443–2755.

Name of Committee: National Institute on

Drug Abuse Special Emphasis Panel, Center

Review Committee.

Date: July 9, 2001.

Time: 8:30 AM to 4 PM.

Agenda: To review and evaluate grant

applications.

Place: Ritz-Carlton Pentagon City, 1250 S.

Hayes Street, Arlington, VA 22202.

Contact Person: Rita Liu, Ph.D, Health

Scientist Administrator, Office of Extramural

Affairs, National Institute on Drug Abuse,

National Institutes of Health, DHHS, 6001

Executive Boulevard, Room 3158, MSC 9547,

Bethesda, MD 20892–9547, (301) 443–2620.

Name of Committee: National Institute on

Drug Abuse Initial Review Group,

Medication Development Research

Subcommittee.

Date: July 9–10, 2001.

Time: 9 AM to 6 PM.

Agenda: To review and evaluate grant

applications.

Place: The Westin Grand, 2350 M Street,

NW, Washington, DC 20037.

Contact Person: Khursheed Asghar, Ph.D,

Chief, Basic Sciences Review Branch, Office

of Extramural Affairs, National Institute on

Drug Abuse, National Institutes of Health,

6001 Executive Boulevard, Room 3158, MSC

9547, Bethesda, MD 20892–9547, (301) 443–

2620.

Name of Committee: National Institute on

Drug Abuse Initial Review Group, Training

and Career Development Subcommittee.

Date: July 10–11, 2001.

Time: 8 AM to 6 PM.

Agenda: To review and evaluate grant

applications.

Place: Ritz Carlton-Pentagon City,

Arlington, VA.

Contact Person: Mark Swieter, Ph.D,

Health Scientist Administrator, Office of

Extramural Affairs, National Institute on

Drug Abuse, National Institutes of Health,

DHHS, 6001 Executive Boulevard, Room

3158, MSC 9547, Bethesda, MD 20892–9547,

(301) 435–1389.

Name of Committee: National Institute on

Drug Abuse Special Emphasis Panel,

Medication Development.

Date: July 10, 2001.

Time: 10 AM to 3 PM.

Agenda: To review and evaluate grant

applications.

Place: The Westin Grand Hotel, 2350 M

Street, NW, Washington, DC 20037.

Contact Person: Rita Liu, Ph.D, Health

Scientist Administrator, Office of Extramural

Affairs, National Institute on Drug Abuse,

National Institutes of Health, DHHS, 6001

Executive Boulevard, Room 3158, MSC 9547,

Bethesda, MD 20892–9547, (301) 443–2620.

Name of Committee: National Institute on

Drug Abuse Special Emphasis Panel,

Responding to Club Drugs and Other

Emerging and Current Drug Abuse Trends.

Date: July 11–12, 2001.

Time: 8 AM to 5 PM.

Agenda: To review and evaluate grant

applications.

Place: The Melrose Hotel, 2430

Pennsylvania Ave., NW., Washington, DC

20037.

Contact Person: William C. Grace, Ph.D,

Deputy Director, Office of Extramural Affairs,

National Institute on Drug Abuse, National

Institutes of Health, DHHS, 6001 Executive

Boulevard, Room 3158, MSC 9547, Bethesda,

MD 20892–9547, (301) 443–2755.

Name of Committee: National Institute on

Drug Abuse Special Emphasis Panel,

Research on GHB and its Precursors.

Date: July 16–17, 2001.

Time: 9 AM to 5 PM.

Agenda: To review and evaluate grant

applications.

Place: Ritz-Carlton Pentagon City, 1250 S.

Hayes Street, Arlington, VA 22202.

Contact Person: Rita Liu, Ph.D, Health

Scientist Administrator, Office of Extramural

29158 Federal Register / Vol. 66, No. 103 / Tuesday, May 29, 2001 / Notices

Affairs, National Institute on Drug Abuse,

National Institutes of Health, DHHS, 6001

Executive Boulevard, Room 3158, MSC 9547,

Bethesda, MD 20892–9547, (301) 443–2620.

Name of Committee: National Institute on

Drug Abuse Special Emphasis Panel, The

Next Generation of Drug Abuse Prevention

Research.

Date: July 17, 2001.

Time: 9 AM to 5 PM.

Agenda: To review and evaluate grant

application.

Place: The Hyatt Regency Hotel, 100

Bethesda Metro Center, Bethesda, MD 20814.

Contact Person: Teresa Levitin, Ph.D,

Director, Office of Extramural Affairs,

National Institute on Drug Abuse, National

Institutes of Health, DHHS, 6001 Executive

Boulevard, Room 3158, MSC 9547, Bethesda,

MD 20892–9547, (301) 443–2755.

Name of Committee: National Institute on

Drug Abuse Special Emphasis Panel, HIV/

AIDS and Drug use Among Adolescents.

Date: July 18, 2001.

Time: 9 AM to 5 PM.

Agenda: To review and evaluate grant

applications.

Place: Hyatt Regency Bethesda, 7400

Wisconsin Avenue, Bethesda, MD 20814.

Contact Person: Marina L. Volkov, Ph.D,

Health Scientist Administrator, Office of

Extramural Program Review, National

Institute on Drug Abuse, National Institutes

of Health, DHHS, 6001 Executive Boulevard,

Room 3158, MSC 9547, Bethesda, MD 20892–

9547, (301) 435–1433.

(Catalogue of Federal Domestic Assistance

Program Nos. 93.277, Drug Abuse Scientist

Development Award for Clinicians, Scientist

Development Awards, and Research Scientist

Awards; 93.278, Drug Abuse National

Research Service Awards for Research

Training; 93.279, Drug Abuse Research

Programs, National Institutes of Health, HHS)

Dated: May 22, 2001.

LaVerne Y. Stringfield,

Director, Office of Federal Advisory

Committee Policy.

[FR Doc. 01–13333 Filed 5–25–01; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Institute on Deafness and

Other Communication Disorders;

Notice of Closed Meeting

Pursuant to section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

meeting.

The meeting will be closed to the

public in accordance with the

provisions set forth in sections

552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,

as amended. The grant applications and

the discussions could disclose

confidential trade secrets or commercial

property such as patentable material,

and personal information concerning

individuals associated with the grant

applications, the disclosure of which

would constitute a clearly unwarranted

invasion of personal privacy.

Name of Committee: National Institute on

Deafness and Other Communication

Disorders Special Emphasis Panel.

Date: June 29, 2001.

Time: 8 AM to 5 PM.

Agenda: To review and evaluate grant

applications.

Place: Hilton Gaithersburg, 620 Perry

Parkway, Gaithersburg, MD 20877.

Contact Person: Craig A. Jordan, Ph.D,

Chief, Scientific Review Branch, NIH/

NIDCD/DER, Executive Plaza South, Room

400C, Bethsda, MD 20892–7180, 301–496–

8683.

(Catalogue of Federal Domestic Assistance

Program Nos. 93.173, Biological Research

Related to Deafness and Communicative

Disorders, National Institutes of Health, HHS)

Dated: May 22, 2001.

LaVerne Y. Stringfield,

Director, Office of Federal Advisory

Committee Policy.

[FR Doc. 01–13334 Filed 5–25–01; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Institute of Dental and

Craniofacial Research; Notice of

Closed Meetings

Pursuant to section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

meetings.

The meetings will be closed to the

public in accordance with the

provisions set forth in sections

552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,

as amended. The grant applications

and/or contract proposals and the

discussions could disclose confidential

trade secrets or commercial property

such as patentable material, and

personal information concerning

individuals associated with the grant

applications and/or contract proposals,

the disclosure of which would

constitute a clearly unwarranted

invasion of personal privacy.

Name of Committee: National Institute of

Dental and Craniofacial Research Special

Emphasis Panel 01–46, Applicant

Interview—P01.

Date: June 7, 2001.

Time: 8 a.m. to 5 p.m.

Agenda: To review and evaluate personal

qualifications and performance, and

competence of individual investigators.

Place: Marriott Pooks Hill, 5151 Pooks Hill

Road, Bethesda, MD 20814.

Contact Person: H. George Hausch, Ph.D.,

Chief, 4500 Center Drive, Natcher Building,

Rm. 4AN44F, National Institutes of Health,

Bethesda, MD 20892, (301) 594–2372.

This notice is being published less than 15

days prior to the meeting due to the timing

limitations imposed by the review and

funding cycle.

Name of Committee: National Institute of

Dental and Craniofacial Research Special

Emphasis Panel 01–58, Review of R44s.

Date: June 15, 2001.

Time: 11 a.m. to 1 p.m.

Agenda: To review and evaluate grant

applications.

Place: 45 Center Drive, Natcher Building,

Conference Room H, Bethesda, MD 20892

(Telephone Conference Call).

Contact Person: Philip Washko, Ph.D.,

DMD, Scientific Review Administrator, 45

Center Drive, Natcher Building, Rm. 4AN44F,

National Institutes of Health, Bethesda, MD

20892, (301) 594–2372.

Name of Committee: National Institute of

Dental and Craniofacial Research Special

Emphasis Panel 01–49, Review of R01s.

Date: June 25, 2001.

Time: 12 p.m. to 1 p.m.

Agenda: To review and evaluate grant

applications.

Place: Natcher Building, Rm. 4AN44F,

Bethesda, MD 20892 (Telephone Conference

Call).

Contact Person: Anna Sandberg, Ph.D.,

Scientific Review Administrator, National

Institute of Dental and Craniofacial Res., 45

Center Drive, Natcher Building, Rm. 4AN44F,

Bethesda, MD 20892, (301) 594–3089.

Name of Committee: National Institute of

Dental and Craniofacial Research Special

Emphasis Panel 01–51, Review of R21s.

Date: July 9, 2001.

Time: 1 p.m. to 3 p.m.

Agenda: To review and evaluate grant

applications.

Place: 45 Center Drive, Bethesda, MD

20892 (Telephone Conference Call).

Contact Person: Anna Sandberg, Ph.D.,

Scientific Review Administrator, National

Institute of Dental and Craniofacial Res., 45

Center Drive, Natcher Building, Rm. 4AN44F,

Bethesda, MD 20892, (301) 594–3089.

Name of Committee: National Institute of

Dental and Craniofacial Research Special

Emphasis Panel 01–47, R01 Reviews.

Date: July 15–16, 2001.

Time: 8 a.m. to 5 p.m.

Agenda: To review and evaluate grant

applications.

Place: The Hyatt Regency Hotel, 100

Bethesda Metro Center, Bethesda, MD 20814.

Contact Person: Anna Sandberg, Ph.D.,

Scientific Review Administrator, National

Institute of Dental and Craniofacial Res., 45

Center Drive, Natcher Building, Rm. 4AN44F,

Bethesda, MD 20892, (301) 594–3089.

Name of Committee: National Institute of

Dental and Craniofacial Research Special

Emphasis Panel 01–42, Applicant—P01.

Date: July 16–17, 2001.

Time: 8:30 a.m. to 5 p.m.

Agenda: To review and evaluate personal

qualifications and performance, and

competence of individual investigators.